RESEARCH GRANTS
Center for Epidemiological Modelling and Analysis Phase II Incubation
Switching virally suppressed HIV-1 infected elderly adults (age above 60 years) without prior confirmed virological failure from current anti-retroviral regimen to bictegravir, emtricitabine and tenofovir alafenamide – BFTAF Study
Efficacy, Safety and effectiveness of injectable cabotegravir and Rilpovorome in improving HIV-1 control in Sub Saharan Africa – A pragmatic phase 3B randomized controlled trial
HIV as a risk factor geriatrics syndromes non communicable diseases and mortality among adults aged 60 years and above in Kenya
Efficacy, Safety and Tolerability of Switching to DTG/3TC Single Tablet Regimen from BFTAF in Older Persons Living with HIV in Kenya
Investigating the optimal management of dolutegravir resistance
Improve Laboratory capacity for diagnosis and surveillance of antimicrobial resistance
